Medtronic (NYSE: MDT) awards RSUs, PSUs and options to CAO
Rhea-AI Filing Summary
Medtronic plc reports that Chief Accounting Officer Denise L. Blomquist received new equity awards and had shares withheld for taxes. On August 3, 2026 she was granted 2,337 restricted stock units vesting 100% on the third anniversary of grant, 2,337 performance share units where each unit is a contingent right to one share with performance conditions measured on April 27, 2029 over a three-year performance period (issuing 2,337 shares at target performance, up to 5,609 at maximum, and possibly 0 if minimum metrics are not met), and 1,366 stock options exercisable at $86.68 per share, vesting 25% per year and expiring August 3, 2036. On July 31, 2026, 212 shares were withheld at $85.39 per share to pay taxes on previously vested restricted stock units, and her reported holdings include 136 shares acquired through dividend reinvestment since the prior report.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,125 shares
Net Buy
4 txns
Insider
Blomquist Denise L.
Role
Chief Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Share Units F4, F5, F6 | 2,337 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F7 | 1,366 | $0.00 | $0.00 |
| Grant/Award | Ordinary Shares F3 | 2,337 | $0.00 | $0.00 |
| Tax Withholding | Ordinary Shares F1, F2 | 212 | $85.39 | $18K |
Holdings After Transaction:
Performance Share Units — 2,337 shares (Direct);
Stock Option (Right to Buy) — 1,366 shares (Direct);
Ordinary Shares — 16,998 shares (Direct)
Footnotes (7)
- F1. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
- F2. Includes 136 shares acquired through dividend reinvestment since the last report filed by the reporting person.
- F3. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
- F4. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- F5. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
- F6. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,337 shares will be issued. If maximum performance metrics are achieved, 5,609 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- F7. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Key Figures
Restricted stock units granted: 2,337 units
Performance share units target payout: 2,337 shares
Performance share units maximum payout: 5,609 shares
+4 more
7 metrics
Restricted stock units granted
2,337 units
RSUs vest 100% on the third anniversary of the grant date
Performance share units target payout
2,337 shares
Shares issued if target performance metrics are achieved over a three-year period
Performance share units maximum payout
5,609 shares
Maximum shares issued if maximum performance metrics are achieved; may vest at 0 shares if minimum not met
Stock options granted
1,366 options
Options become exercisable 25% per year from the first anniversary of August 3, 2026
Option exercise price
$86.68 per share
Exercise price for the 1,366 stock options expiring August 3, 2036
Tax withholding shares
212 shares
Shares withheld at $85.39 per share to pay taxes on vesting RSUs on July 31, 2026
Dividend reinvestment shares
136 shares
Shares acquired through dividend reinvestment since the last report
Key Terms
Performance Share Units, restricted stock units, dividend reinvestment, exercise price
4 terms
restricted stock units financial
"Represents restricted stock units that vest 100% on the third anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend reinvestment financial
"Includes 136 shares acquired through dividend reinvestment since the last report"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
exercise price financial
"These options become exercisable at the rate of 25% of the shares granted"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Medtronic (MDT) grant to Chief Accounting Officer Denise L. Blomquist?
Denise L. Blomquist received 2,337 restricted stock units, 2,337 performance share units and 1,366 stock options on August 3, 2026. The RSUs vest after three years, PSUs depend on performance, and the options carry an $86.68 exercise price and long-dated expiration.
What are the terms of Denise L. Blomquist’s Medtronic (MDT) stock options in this filing?
She received 1,366 stock options with an exercise price of $86.68 per share, expiring on August 3, 2036. These options become exercisable at a rate of 25% of the shares granted per year, beginning on the first anniversary of the grant date.